The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: Rates of development of resistance to some inhibitors of folate metabolism and to artesunate

Annals of Tropical Medicine and Parasitology

Volumn 98, Issue 8, 2004, Pages 763-783

  Stewart, L B ^a   Peters, W ^a   Robinson, B L ^a  

^a NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; CHLORCYCLOGUANIL; CHLORPROGUANIL; CYCLOGUANIL; DAPSONE; PROGUANIL;

ANIMAL MODEL; ARTICLE; DRUG HALF LIFE; FOLATE METABOLISM; MALARIA; MALARIA FALCIPARUM; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII;

ANIMALIA; PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PROTOZOA; RODENTIA;

EID: 10944225208     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485913X13789813917625     Document Type: Article

References (19)

1. Black, R. H. (1973). Malaria in the Australian army in South Vietnam. Successful use of a proguanil-dapsone combination for chemoprophylaxis of chloroquine-resistant falciparum malaria. Medical Journal of Australia, 1, 1265-1270.
2. Hastings, I. M., Watkins, W. M. & White, N. J. (2002). The evolution of drug-resistant malaria: the role of drug elimination half-life. Philosophical Transactions of the Royal Society of London, Series B, 357, 505-519.
3. Hill, J. (1963). Chemotherapy of malaria. Part 2. The antimalarial drugs. In Experimental Chemotherapy, Vol. l, eds Schnitzer, R. J. & Hawking, F. pp. 513-601. New York: Academic Press.
4. Keuter, M., van Eijk, A., Hoogstraate, M., Raasveld, M., van der Ree, M., Ngwawe, W. A., Watkins, W. M., Were, J. B. O. & Brandling-Bennett, A. D. (1990). Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega district, Kenya. British Medical Journal, 301, 466-470.
5. Moore, D. V. & Lanier, J. E. (1961). Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. American Journal of Tropical Medicine and Hygiene, 10, 5-9.
6. Peters, W. (1968). The chemotherapy of rodent malaria. VII. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites, part 2: schizontocidal action in the albino mouse. Annals of Tropical Medicine and Parasitology, 62, 488-494.
7. Peters, W. (1970a). The chemotherapy of rodent malaria, X. Dynamics of drug resistance, part 2: acquisition and loss of chloroquine resistance in Plasmodium berghei observed by continuous bioassay. Annals of Tropical Medicine and Parasitology, 64, 25-40.
8. Peters, W. (1970b). Chemotherapy and Drug Resistance in Malaria. London: Academic Press.
9. Peters, W. (1971). The chemotherapy of rodent malaria. XIV. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites, part 4: the response of normal and drug-resistant strains of Plasmodium berghei. Annals of Tropical Medicine and Parasitology, 65, 123-129.
10. Peters, W. (1987). Chemotherapy and Drug Resistance in Malaria, 2nd Edn. London: Academic Press.
11. Peters, W. (1999). The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of resistance: part 1. Which model is appropriate? Annals of Tropical Medicine and Parasitology, 93, 569-587.
12. Peters, W. & Robinson, B. (1998). Malaria. In Handbook of Animal Models for Infection, eds Zak, O. & Sande, M. pp. 756-771. London: Academic Press.
13. Peters, W. & Robinson, B. I. (1999). The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides. Annals of Tropical Medicine and Parasitology, 93, 325-339.
14. Thompson, P. E., Bayles, A., Olszewski, B. & Waitz, J. A. (1965). Studies on a dihydrotriazine and a sulfone, alone and in combination, against Plasmodium berghei in mice. American Journal of Tropical Medicine and Hygiene, 14, 198-206.
15. Watkins, W. M. & Mosobo, M. (1993). Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 75-78.
16. Watkins, W. M., Brandling-Bennett, A. D., Nevill, C. G., Carter, J. Y., Boriga, D. A., Howells, R. E. & Koech, D. K. (1988). Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 398-403.
17. Wilairatana, P., Kyle, D. E., Looareesuwan, S., Chinwongprom, K., Amradee, S., White, N. J. & Watkins, W. M. (1997). Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand. Annals of Tropical Medicine and Parasitology, 91, 125-132.
18. Winstanley, P. (2001). Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria. Tropical Medicine and International Health, 6, 952-954.
19. Winstanley, P., Watkins, W., Muhia, D., Szwandt, S., Amukoye, E. & Marsh, K. (1997). Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 322-327.